RNA-Based Chimeric Antigen Receptor (CAR) Design Compatible with Broad Range of Immune Effector Cells, Including T (CAR-T) and Natural Killer Cells (CAR-NK) Without the Use of Viral Vectors Capable of ...

Avalon GloboCare secures a patent in Hong Kong for CAR-T and CAR-NK cell technology, enhancing its global intellectual property portfolio. Avalon GloboCare Corp. announced that it has been granted a ...

FREEHOLD, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (ALBT), a developer of precision diagnostic consumer products, today announced the issuance of a new standard patent by the ...

Avalon intends to leverage these resources primarily through its AI-driven subsidiary, Avalon Quantum AI LLC (“AQAI”), as the Company continues scaling its automated commentary video generation ...

Avalon GloboCare Corp. (NASDAQ: ALBT) announced Monday that it has acquired RPM Interactive, Inc., a generative artificial intelligence software company, through an all-stock transaction. The ...

Shares of Avalon GloboCare Corp ALBT are trading sharply higher Thursday morning after Benzinga exclusively reported that the company joined Advanced Micro Devices Inc’s AMD AI Developer Program. Here ...

FREEHOLD, N.J., May 08, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that it has ...